A549 cells infected with RSV Analysis Results (GEO series: GSE147507)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
CEBPB | hg19_v2_chr20_+_48807351_48807384 | 0.56 | 4.4e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr11_-_102668879 Show fit | 1.21 |
ENST00000315274.6
|
matrix metallopeptidase 1 (interstitial collagenase) |
|
chr15_+_41245160 Show fit | 1.20 |
ENST00000444189.2
ENST00000446533.3 |
ChaC, cation transport regulator homolog 1 (E. coli) |
|
chr5_-_150473127 Show fit | 1.06 |
ENST00000521001.1
|
TNFAIP3 interacting protein 1 |
|
chr6_+_32812568 Show fit | 0.94 |
ENST00000414474.1
|
proteasome (prosome, macropain) subunit, beta type, 9 |
|
chr5_-_172756506 Show fit | 0.81 |
ENST00000265087.4
|
stanniocalcin 2 |
|
chrX_-_133792480 Show fit | 0.79 |
ENST00000359237.4
|
placenta-specific 1 |
|
chr11_-_33913708 Show fit | 0.74 |
ENST00000257818.2
|
LIM domain only 2 (rhombotin-like 1) |
|
chr7_+_114562616 Show fit | 0.72 |
ENST00000448022.1
|
MyoD family inhibitor domain containing |
|
chr6_+_31895480 Show fit | 0.68 |
ENST00000418949.2
ENST00000383177.3 ENST00000477310.1 |
complement component 2 Complement factor B; Uncharacterized protein; cDNA FLJ55673, highly similar to Complement factor B |
|
chr6_+_31895467 Show fit | 0.67 |
ENST00000556679.1
ENST00000456570.1 |
complement factor B Complement factor B; Uncharacterized protein; cDNA FLJ55673, highly similar to Complement factor B |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 1.7 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
0.3 | 1.6 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.1 | 1.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 1.4 | GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent(GO:0002479) |
0.1 | 1.2 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.0 | 1.2 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.2 | 1.1 | GO:0052027 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.1 | 0.8 | GO:0001554 | luteolysis(GO:0001554) |
0.1 | 0.8 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.0 | 0.8 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 1.7 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 1.6 | GO:0015030 | Cajal body(GO:0015030) |
0.2 | 1.4 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.2 | 0.5 | GO:0097444 | spine apparatus(GO:0097444) |
0.1 | 0.4 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.1 | 0.3 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
0.0 | 0.3 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.0 | 0.3 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.0 | 0.2 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.0 | 0.2 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 1.7 | GO:0004372 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.5 | 1.6 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.0 | 1.4 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 1.3 | GO:0001848 | complement binding(GO:0001848) |
0.3 | 1.2 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.1 | 0.9 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.8 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.8 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.8 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 1.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.6 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.5 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.0 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 1.5 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.1 | 1.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.9 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.5 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.3 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.3 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.2 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |